|Bid||212.90 x 0|
|Ask||213.20 x 0|
|Day's range||210.30 - 215.60|
|52-week range||166.50 - 245.50|
|Beta (5Y monthly)||0.38|
|PE ratio (TTM)||24.95|
|Earnings date||27 Oct 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||256.70|
Here is how Alimera Sciences (ALIM) and Swedish Orphan Biovitrum (BIOVF) have performed compared to their sector so far this year.
Here is how Swedish Orphan Biovitrum (BIOVF) and CymaBay Therapeutics Inc. (CBAY) have performed compared to their sector so far this year.
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?